http://www.m.webmd.com/a-to-z-guides/news/20160606/longer-use-of-certain-drugs-cuts-recurrence-for-breast-cancer-survivors (relacionado com este artigo anterior)
Citando:
"Many survivors of breast cancers that are sensitive to estrogen are advised to take hormone-suppressing drugs such as tamoxifen for five years, to cut their odds for a recurrence.
Tamoxifen can have onerous side effects, however. Now, new research finds that taking an alternative, and less troublesome, class of medications for a full decade can reduce the risk for recurrence even more -- without affecting a woman's quality of life.
The newer class of hormone-suppressing drugs are called aromatase inhibitors, and include drugs such as letrozole (Femara), anastrozole (Arimidex) and exemestane (Aromasin)."
Críticas / reservas:
http://www.forbes.com/sites/elaineschattner/2016/06/08/major-report-touts-benefits-of-prolonged-femara-use-after-breast-cancer-im-not-convinced/#55fdca8134ff
"
